Algeta To Host Capital Markets Days

OSLO, Norway, Nov. 18, 2013 (GLOBE NEWSWIRE) --
Intended for US media onlyAlgeta ASA (OSE: ALGETA), a company focused onthe development of novel targeted cancer therapeutics, will host Capital MarketsDays this week in Oslo, London and New York.Event summaries and guest speaker details are provided below.Oslo, 18 November 10:00am-2:00pm (CET)KS-Agenda Møtesenter, Haakon VII's gate 9  * Dr Dag Clement Johannessen, Consultant Oncologist, Department of Oncology,    University Hospital of Oslo, Norway  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University    Hospital, Stockholm, SwedenLondon, 19 November 10:00am-2:00pm (GMT)Holborn Bars 2(nd) Floor, 138-142 Holborn  * Dr E. David Crawford, Professor of Surgery (Urology) & Radiation Oncology,    Head Urologic Oncology, University of Colorado, Denver, USA  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University    Hospital, Stockholm, SwedenNew York, 21 November 12.30pm-4:30pm (EDT)Parker Meridien, 118 West 57(th) Street  * Dr Dan George, Director, GU Oncology, Duke Cancer Institute, Duke University    Medical Center, Durham, North Carolina, USA  * Dr Neal D. Shore, Director, CPI, Carolina Urologic Research Center, Atlantic    Urology Clinics, Myrtle Beach, South Carolina, USAThe  event in New  York will be  webcast via, where presentationswill also be made available.                                      ###For further information, please contact: Mike Booth                             +1 646 410 1884 Communications & Corporate Affairs Media enquiries: Mark Swallow                           +44 207 638 9571 Citigate Dewe Rogerson        Kari Watson                            +1 781 235 3060 MacDougall Biomedical Communications Investor enquiries: Tricia Truehart                        +1 646 378 2953 The Trout Group                        ttruehart@troutgroup.comAbout AlgetaAlgeta is a company focused on developing, manufacturing and marketing noveltargeted therapies for patients with cancer. The Company is headquartered inOslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MAperforming commercial marketing operations in the US. Algeta is listed on theOslo Stock Exchange (Ticker: ALGETA). For more information please release:[HUG#1743766]